Combination of pregnancy and breast cancer

Author:

Chernyshova A. L.1ORCID,Chernyakov A. A.1ORCID,Garbukov E. Yu.1ORCID,Tarabanovskaya N. A.1ORCID,Trushchuk Yu. M.1ORCID,Dil O. S.1ORCID,Krasilnikov S. E.2ORCID,Shumeykina A. V.2

Affiliation:

1. Oncology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

2. E.N. Meshalkin National Medical Research Center, Ministry of Health of Russia

Abstract

Breast cancer (BC) occupies the second place in terms of incidence and the first ranking place in terms of mortality among oncopathology in women. The article presents the current state of the problem of the combination of BC and pregnancy, the impact of pregnancy on the course and outcome of breast oncopathology, as well as modern hypotheses for the development of breast cancer during pregnancy. It is shown that the current studies are quite contradictory and in many ways not accurate enough in methodology and materials. We present a clinical case of BC associated with pregnancy. The case is interesting from 2 positions: on the one hand, the patient’s tumor process is associated with pregnancy, on the other hand, there is a very rare combination of HER2/neu- and BRCA1-positive status.According to the presented literature data and our own data, it was concluded that the treatment of patients with BC during pregnancy is a difficult task and is often accompanied by tumor progression, despite the standard treatment regimens. Undoubtedly, this group of patients needs to develop new methodological approaches to antitumor treatment based on a deep analysis of the molecular genetic characteristics of the tumor, the hormonal background in general, and its effect on the tumor process during pregnancy. Such a personalized approach will improve the results of treatment of young patients with BC during pregnancy.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference39 articles.

1. The stаte of oncologicаl cаre to the populаtion of Russiа in 2021. Ed. by А.D. Kаprin, V.V. Stаrinskiy, А.O. Shаkhzаdovа. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2022. 239 p. (In Russ.)

2. World Heаlth Orgаnizаtion (WHO). Available at: http://www.who.int/topics/ru. (In Russ.)

3. Han S.A., Kim S.W. BRCA and breast cancer-related highpenetrance genes. Adv Exp Med Biol 2021;1187:473–90. DOI: 10.1007/978-981-32-9620-6_25

4. Coughlin S.S. Epidemiology of breast cancer in women. Adv Exp Med Biol 2019;1152:9–29. DOI: 10.1007/978-3-030-20301-6_2

5. Schoemaker M.J., Nichols H.B., Wright L.B. et al. Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women. Int J Cancer 2020;147(5):1306–14. DOI: 10.1002/ijc.32892

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3